Research Advances in Targeted Therapy for Facial Skin Diseases
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 May 2026 | Viewed by 8131
Special Issue Editors
Interests: skin; anti-aging medicine; acne; retinoids; photoaging; melasma; rosacea; dermocosmetics
Interests: acne; rosacea; photoaging; skin diseases; inflammatory skin diseases
Interests: adult female acne; rosacea; photoaging; cosmetic dermatology
Special Issue Information
Dear Colleagues,
Facial skin diseases pose unique challenges due to the high visibility, complex anatomy, and psychosocial impact associated with the facial region. While conventional therapies offer symptomatic relief, they often lack specificity and may lead to undesirable effects. This Special Issue highlights the growing shift toward mechanism-driven, targeted interventions that improve efficacy while minimizing off-target actions.
We invite contributions on the discovery and development of novel targeted therapeutics, including small molecules, biologics, peptides, nucleic acid-based agents, and topical nanocarriers designed for enhanced facial skin penetration. Submissions should emphasize target identification and validation—for instance, cytokines, signaling pathways, microbiome components, or neuroimmune interactions—and incorporate robust pharmacological characterization through binding, cellular, and tissue-level assays.
Both original research and comprehensive review articles are invited for submission.
Dr. Edileia Bagatin
Dr. Marco Alexandre Rocha
Dr. Diogo Pazzini Bomfim
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- facial dermatoses
- targeted therapy
- biologics
- precision dermatology
- acne vulgaris
- topical drug delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
